2023-04-24 16:32:22 ET
- IDEAYA Biosciences ( NASDAQ: IDYA ) on Monday announced a proposed public stock offering of up to $150M.
- IDYA also said it intends to grant the underwriters a 30-day option to purchase up to $22.5M of shares of its common stock.
- The announcement comes after the biotech earlier in the day said it would begin a mid-to-late stage trial of its lead program for experimental cancer therapies, sending its shares soaring .
- IDYA stock eventually closed with a hefty gain of 35.7% at $20.26.
For further details see:
IDEAYA announces $150M stock offering